Apoptotic Extracellular Vesicles Derived from Human Umbilical Vein Endothelial Cells Promote Skin Repair by Enhancing Angiogenesis: From Death to Regeneration
Jinzhao Liu,Jia Dong,Xibo Pei
DOI: https://doi.org/10.2147/ijn.s441453
IF: 7.033
2024-01-17
International Journal of Nanomedicine
Abstract:Jinzhao Liu, 1, 2, &ast Jia Dong, 1, &ast Xibo Pei 1, 2 1 State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, 610041, People's Republic of China; 2 Department of Prosthodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, 610041, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jia Dong; Xibo Pei, Email ; Purpose: The promotion of angiogenesis is an effective strategy for skin wound repair. While the transplantation of endothelial cells has shown promise in vascularization, the underlying mechanism remains unclear. Recent studies have suggested that transplanted cells undergo apoptosis in a short period and release apoptotic extracellular vesicles (ApoEVs) that may have therapeutic potential. Methods: In this study, we isolated ApoEVs from human umbilical vein endothelial cells (HUVECs) and characterized their properties. In vitro, we assessed the effects of ApoEVs on the proliferation, migration, and differentiation of endothelial cells and fibroblasts. In vivo, we investigated the therapeutic role of ApoEVs-AT in full-thickness skin wounds, evaluating wound closure rate, re-epithelialization, granulation tissue formation, vascularization, scar area, and collagen 3(Col3)/collagen 1(Col 1) ratio. Results: ApoEVs derived from HUVECs displayed typical characteristics. In vitro, ApoEVs significantly enhanced the proliferation, migration, tube formation, and expression of angiogenic-related genes in endothelial cells and slightly promoted the proliferation and migration of fibroblasts. In vivo, ApoEVs improved the wound closure rate, re-epithelialization, the formation of granulation tissue, and vascularization. Besides, ApoEVs reduced scar formation, accompanied by an increase in the Col 3/ Col 1 ratio. Conclusion: Given their abundant source and effectiveness, this study provided a novel approach for angiogenesis in tissue regeneration and deepened the understanding of from death to regeneration. Keywords: apoptotic extracellular vesicles, human umbilical vein endothelial cells, skin regeneration, angiogenesis The skin serves as the primary barrier against external pathogens and any serious damage to it can impact human health and quality of life. Stimulating angiogenesis, the formation of new blood vessels is one of the most effective approaches for skin tissue repair. 1 Vascularization plays a critical role in facilitating nutrient delivery, maintaining oxygen levels, supporting cellular proliferation, and promoting tissue regeneration. 2 In previous studies, endothelial cells have been used for promoting vascularization in tissue repair and regeneration. 3–7 However, the safety and ethical concerns associated with live cells have posed significant limitations in clinical translational applications. 8 As a result, researchers have started investigating the mechanisms through which live cells exert therapeutic effects and have been searching for alternative solutions. In recent years, it has become widely accepted that transplanted live cells release growth factors, cytokines, and extracellular vesicles, such as exosomes, through paracrine signaling to exert therapeutic effects. 9,10 However, growing studies have revealed that transplanted cells undergo extensive apoptosis within a short time, leading to the release of apoptotic extracellular vesicles (ApoEVs), which play a crucial role in therapeutic processes. 11–13 Therefore, it has been suggested that ApoEVs may significantly contribute to the therapeutic abilities of transplanted cells. Furthermore, studies have demonstrated that direct delivery of apoptotic mesenchymal stem cells (MSCs) or ApoEVs derived from apoptotic MSCs offers advantages over viable MSCs. 14,15 Previous studies have primarily utilized bone marrow mesenchymal stem cells (BMSCs) 13,16–22 as the source of ApoEVs. Other cell types, including adipose mesenchymal stem cells (ASCs), 18 embryonic mesenchymal stem cells (ESCs), 23 umbilical cord mesenchymal stem cells (UMSCs), 23 and deciduous pulp stem cells, 24 as well as whole adipose tissue, 25 have also been selected in various studies. Among them, ApoEVs, isolated from BMSCs 22 and deciduous pulp stem cells, 24 were reported to regulate endothelial cell behavior and promote angiogenesis. Besides, ApoEVs, isolated from human embryonic stem cells (ESCs), 23 -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology